BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34310723)

  • 1. Multifocality is not associated with worse survival in sporadic pancreatic neuroendocrine tumors.
    Gudmundsdottir H; Graham RP; Sonbol MB; Smoot RL; Truty MJ; Kendrick ML; Nagorney DM; Habermann EB; Halfdanarson TR; Cleary SP
    J Surg Oncol; 2021 Dec; 124(7):1077-1084. PubMed ID: 34310723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal surgical management of unifocal vs. multifocal NF-PNETs: a respective cohort study.
    Kim J; Hong SS; Kim SH; Hwang HK; Kang CM
    World J Surg Oncol; 2024 Apr; 22(1):115. PubMed ID: 38671431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic Ultrasound Features of Multiple Endocrine Neoplasia Type 1-Related versus Sporadic Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Study.
    Tamagno G; Scherer V; Caimo A; Bergmann SR; Kann PH
    Digestion; 2018; 98(2):112-118. PubMed ID: 29698969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Prognostic Factors in Sporadic and Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors.
    Kfir SK; Halperin R; Percik R; Uri I; Halpern N; Shlomai G; Laish I; Tirosh A; Tirosh A
    Horm Metab Res; 2021 May; 53(5):319-325. PubMed ID: 33878789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Direct Comparison of Patients With Hereditary and Sporadic Pancreatic Neuroendocrine Tumors: Evaluation of Clinical Course, Prognostic Factors and Genotype-Phenotype Correlations.
    Soczomski P; Jurecka-Lubieniecka B; Krzywon A; Cortez AJ; Zgliczynski S; Rogozik N; Oczko-Wojciechowska M; Pawlaczek A; Bednarczuk T; Jarzab B
    Front Endocrinol (Lausanne); 2021; 12():681013. PubMed ID: 34122352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodality Imaging of the Pancreatic Neuroendocrine Tumors.
    Singh A; Hines JJ; Friedman B
    Semin Ultrasound CT MR; 2019 Dec; 40(6):469-482. PubMed ID: 31806146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place.
    de Mestier L; Gaujoux S; Cros J; Hentic O; Vullierme MP; Couvelard A; Cadiot G; Sauvanet A; Ruszniewski P; Richard S; Hammel P
    Ann Surg; 2015 Aug; 262(2):384-8. PubMed ID: 25185468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and postoperative survival in patients with sporadic versus multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: An international cohort study.
    Bergquist JR; Shariq OA; Li AY; Worth PJ; Chatzizacharias N; Soonawalla Z; Athanasopoulos P; Toumpanakis C; Hansen P; Parks RW; Connor S; Parker K; Koea J; Srinivasa S; Ielpo B; Lopez EV; Norton JA; Lawrence B; Visser BC;
    Surgery; 2022 Aug; 172(2):723-728. PubMed ID: 35577612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors.
    Titan AL; Norton JA; Fisher AT; Foster DS; Harris EJ; Worhunsky DJ; Worth PJ; Dua MM; Visser BC; Poultsides GA; Longaker MT; Jensen RT
    JAMA Netw Open; 2020 Nov; 3(11):e2024318. PubMed ID: 33146734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience.
    Ito H; Abramson M; Ito K; Swanson E; Cho N; Ruan DT; Swanson RS; Whang EE
    J Gastrointest Surg; 2010 May; 14(5):891-8. PubMed ID: 20224984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors.
    Rosenberg AM; Friedmann P; Del Rivero J; Libutti SK; Laird AM
    Surgery; 2016 Jan; 159(1):302-9. PubMed ID: 26547726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors.
    Bilimoria KY; Bentrem DJ; Merkow RP; Tomlinson JS; Stewart AK; Ko CY; Talamonti MS
    J Am Coll Surg; 2007 Oct; 205(4):558-63. PubMed ID: 17903729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
    Yadav S; Sharma P; Zakalik D
    Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome and long-term survival of 150 consecutive patients with pancreatic neuroendocrine tumors: A comprehensive analysis by the World Health Organization 2010 grading classification.
    Deng BY; Liu F; Yin SN; Chen AP; Xu L; Li B
    Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):261-268. PubMed ID: 29307515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
    Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A
    Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1.
    Weisbrod AB; Nilubol N; Weinstein LS; Simonds WF; Libutti SK; Jensen RT; Marx SJ; Kebebew E
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E109-14. PubMed ID: 23093487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
    Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of Pancreatic Neuroendocrine Tumors.
    Mohindroo C; McAllister F; De Jesus-Acosta A
    Hematol Oncol Clin North Am; 2022 Oct; 36(5):1033-1051. PubMed ID: 36154786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors.
    Crippa S; Partelli S; Zamboni G; Scarpa A; Tamburrino D; Bassi C; Pederzoli P; Falconi M
    Surgery; 2014 Jan; 155(1):145-53. PubMed ID: 24646958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment.
    Ro C; Chai W; Yu VE; Yu R
    Chin J Cancer; 2013 Jun; 32(6):312-24. PubMed ID: 23237225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.